| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jul 19, 2024 | Director, President and CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,466 | -- | 7,466 | |
| Jul 19, 2024 | SVP Quality and Regulatory | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 735 | $7.18 | 41,526 | |
| Jul 19, 2024 | SVP International | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 1,983 | $7.18 | 39,081 | |
| Jul 19, 2024 | EVP and CFO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 2,585 | $7.18 | 171,011 | |
| Jul 17, 2024 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 20,541 | -- | 87,043 | |
| Jul 17, 2024 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 20,541 | -- | 37,582 | |
| Jul 17, 2024 | SVP/GM, Vascular Access | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 12,350 | -- | 65,366 | |
| Jul 17, 2024 | SVP/GM, Vascular Access | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 24,699 | -- | 24,699 | |
| Jul 17, 2024 | SVP/GM, Vascular Access | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 24,240 | -- | 24,240 | |
| Jul 17, 2024 | SVP/GM, Vascular Access | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 6,600 | -- | 70,187 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.